Nanoaerosols reduce required effective dose of liposomal levofloxacin against pulmonary murine Francisella tularensis subsp. novicida infection

BACKGROUND: The Institute of Theoretical and Experimental Biophysics in Moscow recently developed a new nanoaerosol generator. This study evaluated this novel technology, which has the potential to enhance therapeutic delivery, with the goal of using the generator to treat pulmonary Francisella tula...

Descripción completa

Detalles Bibliográficos
Autores principales: Propst, Crystal N., Nwabueze, Albert O., Kanev, Igor L., Pepin, Rachel E., Gutting, Bradford W., Morozov, Victor N., van Hoek, Monique L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835885/
https://www.ncbi.nlm.nih.gov/pubmed/27090889
http://dx.doi.org/10.1186/s12951-016-0182-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835885/
https://www.ncbi.nlm.nih.gov/pubmed/27090889
http://dx.doi.org/10.1186/s12951-016-0182-0

Ejemplares similares